ScholarIQanswers from OpenAlex & ORCID
Salim Yusuf
ResearcherPublications, citations & collaboration network
Salim Yusuf is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Salim Yusuf have?
ScholarIQindexed works
Salim Yusuf has 2,143 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Salim Yusuf have?
ScholarIQcitation count
Salim Yusuf has 292,506 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Salim Yusuf?
ScholarIQh-index
Salim Yusuf has an h-index of 262 in OpenAlex.
What is the i10-index of Salim Yusuf?
ScholarIQi10-index
Salim Yusuf has an i10-index of 1,291 in OpenAlex.
What is the ORCID of Salim Yusuf?
ScholarIQorcid
The ORCID for Salim Yusuf is on the source record.
What is the OpenAlex record for Salim Yusuf?
ScholarIQopenalex
The OpenAlex for Salim Yusuf is on the source record.
What are the most-cited papers on Salim Yusuf?
ScholarIQmost cited works
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf, John W. Eikelboom, Jonas Oldgren, Amit Parekh, Janice Pogue, Paul Reilly, Ellison Themeles, Jeanne Varrone, Susan Wang, Marco Alings, Denis Xavier, Jun Zhu, Rafael Díaz, Basil S. Lewis, Harald Darius, Hans‐Christoph Diener, Campbell Joyner, Lars Wallentin
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study
Martin O’Donnell, Denis Xavier, Lisheng Liu, Hongye Zhang, Siu Lim Chin, Rao Ps, Sumathy Rangarajan, Shofiqul Islam, Prem Pais, Matthew McQueen, Charles Mondo, Albertino Damasceno, Patricio López‐Jaramillo, Graeme J. Hankey, Antonio L Dans, Khalid Yusoff, Thomas Truelsen, Hans‐Christoph Diener, Ralph L. Sacco, Danuta Ryglewicz, Anna Członkowska, Christian Weimar, Xingyu Wang, Salim Yusuf
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
Salim Yusuf, Marc A. Pfeffer, Karl Swedberg, Christopher B. Granger, Peter Held, John J.V. McMurray, Eric L. Michelson, Bertil Olofsson, Jan Östergren
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
John J.V. McMurray, Jan Östergren, Karl Swedberg, Christopher B. Granger, Peter Held, Eric L. Michelson, Bertil Olofsson, Salim Yusuf, Marc A. Pfeffer
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
John W. Eikelboom, Stuart J. Connolly, Jackie Bosch, Gilles R. Dagenais, Robert G. Hart, Olga Shestakovska, Rafael Díaz, Marco Alings, Eva Lonn, Sonia S. Anand, Petr Widimský, Masatsugu Hori, Álvaro Avezum, Leopoldo Soares Piegas, Kelley R. Branch, Jeffrey L. Probstfield, Deepak L. Bhatt, Jun Zhu, Yan Liang, Aldo P. Maggioni, Patricio López‐Jaramillo, Martin O’Donnell, Ajay K. Kakkar, Keith A.A. Fox, Alexander Parkhomenko, Georg Ertl, Stefan Störk, Mátyás Keltai, Lars Rydén, Nana Pogosova, Antonio L Dans, Fernando Laņas, Patrick Commerford, Christian Torp‐Pedersen, Tomek J. Guzik, Peter Verhamme, Dragoş Vinereanu, Jae‐Hyung Kim, Andrew M. Tonkin, Basil S. Lewis, Camilo Félix, Khalid Yusoff, Philippe Gabríel Steg, Kaj Metsärinne, Nancy Cook Bruns, Frank Misselwitz, Edmond Chen, Darryl P. Leong, Salim Yusuf